|
Re: CASH
|
1
|
Resverlogix Corp.
|
Oct 05, 2019 12:29PM
|
|
Re: Report Of Exempt Distribution.
|
1
|
Zenith Epigenetics
|
Apr 30, 2024 06:30AM
|
|
Re: No mention of efficacy again...
|
1
|
Resverlogix Corp.
|
Mar 29, 2019 10:47AM
|
|
Re: Wow! What’s with the continued market drop?
|
1
|
Resverlogix Corp.
|
Sep 17, 2019 05:01PM
|
|
Re: The FDA's highly arbitrary decisions
|
1
|
Resverlogix Corp.
|
Jun 07, 2021 03:46PM
|
|
Re: some action on the WTS 2021 warrants - up .25 or 83.33% to .55
|
1
|
Resverlogix Corp.
|
Jan 20, 2020 11:52AM
|
|
Re: No word on...
|
1
|
Resverlogix Corp.
|
Jul 12, 2021 12:58PM
|
|
Re: No word on...
|
1
|
Resverlogix Corp.
|
Jul 15, 2021 10:37AM
|
|
Re: Don's latest presentation
|
1
|
Resverlogix Corp.
|
Sep 22, 2020 01:01PM
|
|
Re: OTC- ZHCLF -TFSA
|
1
|
Zenith Epigenetics
|
Dec 14, 2020 01:50PM
|
|
Re: Resverlogix Announces Publication on Apabetalone in Clinical Epigenetics
|
1
|
Resverlogix Corp.
|
Jul 15, 2019 01:21PM
|
|
Re: Financing
|
1
|
Resverlogix Corp.
|
Feb 04, 2021 01:54PM
|
|
Re: TLD Confidence
|
1
|
Resverlogix Corp.
|
Aug 27, 2019 02:54PM
|
|
Re: A new day for RVX
|
1
|
Resverlogix Corp.
|
May 13, 2021 09:52AM
|
|
Re: The chart set up looks awesome imo....
|
1
|
Resverlogix Corp.
|
Dec 03, 2019 04:12PM
|
|
Re: MD&A
|
1
|
Resverlogix Corp.
|
Sep 14, 2020 12:13PM
|
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
1
|
Resverlogix Corp.
|
May 09, 2022 09:26AM
|
|
Re: Apabetalone’s Positive Effect on Hospitalized Patients Involving HF - simple suggestion
|
1
|
Resverlogix Corp.
|
Jan 13, 2021 05:47PM
|
|
Re: According to the TMX website there are only 5 million RVX.WT.A oustanding....
|
1
|
Resverlogix Corp.
|
Jun 20, 2019 07:42PM
|
|
Re: Contradictory short interest data for OTC RVXCF
|
1
|
Resverlogix Corp.
|
Aug 08, 2019 06:57AM
|
